A method for assessing quality of control from glucose profiles.

A method for assessing quality of control from glucose profiles.

AIM: As the practice of multiple assessments of glucose concentration throughout the day increases for people with diabetes, there is a need for an assessment of glycaemic control weighted for the clinical risks of both hypoglycaemia and hyperglycaemia. METHODS: We have developed a methodology to re...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Hill, N, Hindmarsh, P, Stevens, R, Stratton, I, Levy, J, Matthews, DR
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2007

Míreanna comhchosúla

Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups
de réir: Hill, N, et al.
Foilsithe / Cruthaithe: (2011)

Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.
de réir: Hill, N, et al.
Foilsithe / Cruthaithe: (2011)

Methodology for quantifying fasting glucose homeostasis in type 2 diabetes: observed variability and lability.
de réir: Hill, N, et al.
Foilsithe / Cruthaithe: (2013)

A distribution method for analysing the baseline of pulsatile endocrine signals as exemplified by 24-hour growth hormone profiles.
de réir: Matthews, DR, et al.
Foilsithe / Cruthaithe: (1991)

Rate of change (modulation) of serum growth hormone concentrations is a more important factor in determining growth rate than duration of exposure.
de réir: Hindmarsh, P, et al.
Foilsithe / Cruthaithe: (1992)

Glycaemic risk assessment in children and young people with Type 1 diabetes mellitus.
de réir: Hill, N, et al.
Foilsithe / Cruthaithe: (2009)

Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy.
de réir: Peters, C, et al.
Foilsithe / Cruthaithe: (2013)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
de réir: Stevens, R, et al.
Foilsithe / Cruthaithe: (2002)

Hepatic glucose output in humans measured with labeled glucose to reduce negative errors.
de réir: Levy, J, et al.
Foilsithe / Cruthaithe: (1989)

Cyclical variation in HbA1c values during the year: clinical and research implications.
de réir: Hill, N, et al.
Foilsithe / Cruthaithe: (2013)

Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study.
de réir: O'Riordan, S, et al.
Foilsithe / Cruthaithe: (2009)

Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
de réir: Stratton, I, et al.
Foilsithe / Cruthaithe: (1997)

GLUCOSE AND FREE FATTY-ACID TURNOVER AND ASSESSMENT OF INSULIN SENSITIVITY BY A CONSTANT INFUSION OF GLUCOSE TEST
de réir: Levy, J, et al.
Foilsithe / Cruthaithe: (1987)

Development of an in silico model to extrapolate whole body glucose - insulin homeostasis by altering tissue specific effects, simulation of SGLT-2 inhibition in type 2 diabetes
de réir: Hill, N, et al.
Foilsithe / Cruthaithe: (2009)

Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity.
de réir: Turner, R, et al.
Foilsithe / Cruthaithe: (1990)

Reproducibility of 24-hour serum growth hormone profiles in man.
de réir: Saini, S, et al.
Foilsithe / Cruthaithe: (1991)

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
de réir: Clarke, P, et al.
Foilsithe / Cruthaithe: (2001)

Prevalence and pathophysiology of impaired glucose tolerance in three different high-risk white groups.
de réir: Page, R, et al.
Foilsithe / Cruthaithe: (1993)

Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2.
de réir: Hill, N, et al.
Foilsithe / Cruthaithe: (2013)

A COMPARISON OF 24HR GROWTH-HORMONE PROFILES MEASURED BY BIOASSAY AND AN IMMUNORADIOMETRIC METHOD
de réir: Sandhu, R, et al.
Foilsithe / Cruthaithe: (1987)

Growth hormone secretion in children determined by time series analysis.
de réir: Hindmarsh, P, et al.
Foilsithe / Cruthaithe: (1988)

Follow-up of Intensive Glucose Control in Type 2 Diabetes Reply
de réir: Holman, R, et al.
Foilsithe / Cruthaithe: (2009)

Changes in gonadotrophin secretion during childhood and puberty.
de réir: Bridges, N, et al.
Foilsithe / Cruthaithe: (1994)

Growth and the growth hormone axis in prepubertal children with asthma.
de réir: Crowley, S, et al.
Foilsithe / Cruthaithe: (1995)

Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
de réir: Levy, J, et al.
Foilsithe / Cruthaithe: (1991)

Apolipoprotein E genotype is not associated with islet amyloid as assessed by disease severity in type 2 diabetes.
de réir: Powell, D, et al.
Foilsithe / Cruthaithe: (1999)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
de réir: Stevens, R, et al.
Foilsithe / Cruthaithe: (2004)

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).
de réir: Clarke, P, et al.
Foilsithe / Cruthaithe: (2005)

GLUCOSE-TOLERANCE AND BETA-CELL FUNCTION ASSESSED BY CONTINUOUS INFUSION OF GLUCOSE AND ORAL GLUCOSE-TOLERANCE TEST
de réir: Levy, J, et al.
Foilsithe / Cruthaithe: (1992)

The relationship between height velocity and growth hormone secretion in short prepubertal children.
de réir: Hindmarsh, P, et al.
Foilsithe / Cruthaithe: (1987)

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
de réir: Matthews, DR, et al.
Foilsithe / Cruthaithe: (2004)

The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
de réir: Spoudeas, H, et al.
Foilsithe / Cruthaithe: (1992)

The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
de réir: Massoud, A, et al.
Foilsithe / Cruthaithe: (1996)

Continuous subcutaneous growth hormone releasing factor analogue augments growth hormone secretion in normal male subjects with no desensitization of the somatotroph.
de réir: Brain, C, et al.
Foilsithe / Cruthaithe: (1988)

Evolution of growth hormone neurosecretory disturbance after cranial irradiation for childhood brain tumours: a prospective study.
de réir: Spoudeas, H, et al.
Foilsithe / Cruthaithe: (1996)

The relationship between endogenous testosterone and gonadotrophin secretion.
de réir: Bridges, N, et al.
Foilsithe / Cruthaithe: (1993)

CONTRIBUTION OF GROWTH-HORMONE PULSE AMPLITUDE AND PERIODICITY TO MID CHILDHOOD GROWTH - AN ASSESSMENT BY TIME SEQUENCE-ANALYSIS
de réir: Hindmarsh, P, et al.
Foilsithe / Cruthaithe: (1988)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
de réir: Adler, A, et al.
Foilsithe / Cruthaithe: (2005)

Of insulin resistance and normalcy.
de réir: Turner, R, et al.
Foilsithe / Cruthaithe: (1992)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
de réir: Turner, R, et al.
Foilsithe / Cruthaithe: (1998)